quantisnow
FeedTopReportsPricing
⌘K
Live feed
20:21:28·197d
INSIDERFiling
Titan Pharmaceuticals Inc. logo

Director Ben-Tzvi Avraham returned 3,313 shares to the company, closing all direct ownership in the company (SEC Form 4)

TTNP· Titan Pharmaceuticals Inc.
Health Care
Original source

Companies

  • TTNP
    Titan Pharmaceuticals Inc.
    Health Care

Related

  • SEC158d
    SEC Form EFFECT filed by Titan Pharmaceuticals Inc.
  • SEC158d
    SEC Form EFFECT filed by Titan Pharmaceuticals Inc.
  • SEC158d
    SEC Form EFFECT filed by Titan Pharmaceuticals Inc.
  • SEC158d
    SEC Form EFFECT filed by Titan Pharmaceuticals Inc.
  • SEC158d
    SEC Form EFFECT filed by Titan Pharmaceuticals Inc.
  • SEC158d
    SEC Form EFFECT filed by Titan Pharmaceuticals Inc.
  • SEC191d
    SEC Form 15-12G filed by Titan Pharmaceuticals Inc.
  • SEC196d
    SEC Form POS AM filed by Titan Pharmaceuticals Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022